| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 06/04/2013 | US8455660 1-(sulfonyl)-N-phenylpyrrolidine-2-carboxamides for the identification of biological and pharmacological activity |
| 06/04/2013 | US8455529 Kinase inhibitors |
| 06/04/2013 | US8455507 Aminopyrimidines useful as kinase inhibitors |
| 06/04/2013 | US8455498 Inhibitors of histone deacetylase |
| 06/04/2013 | US8455492 Methods for treating retinal diseases |
| 06/04/2013 | US8455479 Heterocyclic compounds |
| 06/04/2013 | CA2545660C Heterocyclic inhibitors of mek and methods of use thereof |
| 06/04/2013 | CA2545659C Bicyclic inhibitors of mek |
| 06/04/2013 | CA2534885C 2-(quinoxalin-5-ylsulfonylamino)-benzamide compounds as cck2 modulators |
| 05/30/2013 | WO2013077406A1 Aromatic amine derivative, material for organic electroluminescent element, and organic electroluminescent element |
| 05/30/2013 | WO2013076063A1 Novel pyrrolidine derivatives as inhibitors of cathepsin |
| 05/30/2013 | WO2013075167A1 Binding agent |
| 05/30/2013 | US20130137878 Process for manufacture of telmisartan |
| 05/30/2013 | US20130137877 Antiviral compounds |
| 05/30/2013 | US20130137865 Heteroaryl-pyrazole derivative |
| 05/30/2013 | US20130137740 Combretastatin analogs for use in the treatment of cancer |
| 05/30/2013 | US20130137700 Fused heterocyclic ring compound |
| 05/30/2013 | US20130137699 Therapeutic compounds |
| 05/30/2013 | US20130137695 Substituted 4-(4-fluoro-3-(piperazine-1-carbonyl)benzyl)phthalazin-1(2h)-one derivatives as poly (adp-ribose) polymerase-1 inhibitors |
| 05/30/2013 | US20130137690 4-carboxybenzylamino derivatives as histone deacetylase inhibitors |
| 05/30/2013 | US20130137688 Novel compounds |
| 05/30/2013 | US20130137687 Novel pyrrolidine derivatives |
| 05/30/2013 | US20130137686 Benzene, pyridine, and pyridazine derivatives |
| 05/30/2013 | US20130137679 Novel Functionally Selective Ligands of Dopamine D2 Receptors |
| 05/30/2013 | US20130137677 Bicyclic Azaheterocyclic Carboxamides |
| 05/30/2013 | US20130137675 Heterocyclic compound and use thereof |
| 05/30/2013 | US20130137674 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 05/30/2013 | US20130137673 Inhibitors of jak |
| 05/30/2013 | US20130137661 Gonadotropin Releasing Hormone Receptor Antagonist, Preparation Method Thereof And Pharmaceutical Composition Comprising The Same |
| 05/30/2013 | US20130137660 Inhibitors of kinase activity |
| 05/30/2013 | US20130137635 Tryptophan hydroxylase inhibitors for the treatment of metastatic bone disease |
| 05/30/2013 | CA2856306A1 Selective kinase inhibitors |
| 05/30/2013 | CA2856301A1 Pyrazine kinase inhibitors |
| 05/30/2013 | CA2854569A1 Novel pyrrolidine derivatives as inhibitors of cathepsin |
| 05/29/2013 | EP2597089A1 Tricyclic heterocyclic compounds |
| 05/29/2013 | EP2597088A1 P2x4 receptor antagonist |
| 05/29/2013 | EP2595981A1 Novel hetaryl (thio)carboxamide compounds for controlling invertebrate pests |
| 05/29/2013 | EP2595967A2 Tetrazine-trans-cyclooctene ligation for the rapid construction of radionuclide labeled probes |
| 05/29/2013 | EP2595964A1 Pyrimidine compounds as inhibitors of protein kinases ikk epsilon and/or tbk-1, processes for their preparation, and pharmaceutical compositions containing them |
| 05/29/2013 | CN1747730B Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity |
| 05/29/2013 | CN103121994A Salt of pyrrole derivative |
| 05/29/2013 | CN103121973A Pyrimidine urea derivatives as kinase inhibitors |
| 05/29/2013 | CN103121972A Pyrimidine urea derivatives as kinase inhibitors |
| 05/29/2013 | CN102219750B N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase |
| 05/29/2013 | CN101959970B Azo pigment composition, process for production of the composition, dispersions containing the composition, colored compositions and jet printing ink |
| 05/29/2013 | CN101941939B Polyfunctional carbazole derivative oxime ester compound and preparation method and light polymerization initiator thereof |
| 05/29/2013 | CN101184734B Compound and methods of treating cell proliferation disorders |
| 05/28/2013 | US8450486 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors |
| 05/28/2013 | US8450484 TRPV4 antagonists |
| 05/28/2013 | US8450478 Cyclic guanidine ionic liquid |
| 05/28/2013 | US8450361 Substituted indole and azaindole oxoacetyl piperazinamide derivatives |
| 05/28/2013 | US8450354 Substituted imidazo[1,2-b]pyridazine derivatives, pharmaceutical compositions, and methods of use as β-secretase inhibitors |
| 05/28/2013 | US8450304 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of CCR2 |
| 05/28/2013 | CA2740262C 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands |
| 05/28/2013 | CA2735184C Heteroaryls amide derivatives and their use as glucokinase activators |
| 05/28/2013 | CA2720946C Compounds and compositions as protein kinase inhibitors |
| 05/28/2013 | CA2561066C Antiviral 4-aminocarbonylamino-substituted imidazole compounds |
| 05/28/2013 | CA2553243C Pyrrolo pyrimidine derivatives useful for treating proliferative diseases |
| 05/28/2013 | CA2547887C Protein modifier production inhibitor |
| 05/28/2013 | CA2539823C Hemiasterlin derivatives and uses thereof |
| 05/28/2013 | CA2485346C Human adam-10 inhibitors |
| 05/23/2013 | WO2013074459A1 Methods and compositions associated with the granulocyte colony-stimulating factor receptor |
| 05/23/2013 | WO2013073859A1 Novel organic electroluminescence compounds and organic electroluminescence device comprising the same |
| 05/23/2013 | WO2013073577A1 Dihydroxy aromatic heterocyclic compound |
| 05/23/2013 | WO2013072825A1 Phtalazinone derivatives as mpegs -1 inhibitors |
| 05/23/2013 | WO2013072502A1 Pharmaceutically active pyrazine derivatives |
| 05/23/2013 | WO2013071880A1 Nitrogen-containing fused ring compounds for use as crth2 antagonists |
| 05/23/2013 | WO2013071697A1 Aminoquinazoline derivatives and their salts and methods of use |
| 05/23/2013 | WO2013019079A9 Composition containing 5-hydroxyindole compounds or sponge scalarispongia sp. extracts as active ingredients for prevention and treatment of cancer diseases |
| 05/23/2013 | WO2012169785A9 Symmetrically structured quinazoline derivatives |
| 05/23/2013 | US20130131338 Substituted diketopiperazines as oxytocin antagonists |
| 05/23/2013 | US20130131321 LIGANDS FOR ANTIBODY AND Fc-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMATOGRAPHY |
| 05/23/2013 | US20130131132 N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 05/23/2013 | US20130131084 Use of derivatives of indoles for the treatment of cancer |
| 05/23/2013 | US20130131074 Pyridone and pyridazone analogues as gpr119 modulators |
| 05/23/2013 | US20130131062 Pyridazinones and furan-containing compounds |
| 05/23/2013 | US20130131061 Novel Estrogen Receptor Ligands |
| 05/23/2013 | US20130131060 3-(indolyl)- or 3-(azaindolyl)- 4-arylmaleimide compounds and their use in tumor treatment |
| 05/23/2013 | US20130131059 Method for treating ophthalmic diseases using kinase inhibitor compounds in prodrug forms |
| 05/23/2013 | US20130131047 Pharmacokinetically improved compounds |
| 05/23/2013 | US20130131040 Pyrazine kinase inhibitors |
| 05/23/2013 | US20130131037 2-(heterocyclylbenzyl)pyridazinone derivatives |
| 05/23/2013 | US20130131035 Carboxamides as inhibitors of voltage-gated sodium channels |
| 05/23/2013 | US20130129813 Targeted delivery using tissue-specific peptidomimetic ligands |
| 05/23/2013 | US20130129812 Novel compositions and methods for treating cancer |
| 05/23/2013 | US20130129795 Inhibition and dispersion of bacterial biofilms with imidazole-triazole derivatives |
| 05/23/2013 | US20130126856 Compound having indenocarbazole ring structure, and organic electroluminescent device |
| 05/23/2013 | US20130126429 Amine sulfide scavengers, methods of using, and methods of making |
| 05/23/2013 | CA2856100A1 Nitrogen-containing fused ring compounds as crth2 antagonists |
| 05/23/2013 | CA2851151A1 Aminoquinazoline derivatives and their salts and methods of use |
| 05/22/2013 | EP2594567A1 Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof |
| 05/22/2013 | EP2594555A1 HETEROCYCLIC COMPOUND, AND p27 KIP1 DEGRADATION INHIBITOR |
| 05/22/2013 | EP2593448A1 New cristalline forms of n-[2-[[(2,3-difluoropheny)methyl)thio]-6-{[(1r,2s)-2,3- dihydroxy-1-methylpropyl]oxy}-4-pyrimidinyl]-1-azetidinesulfonamide |
| 05/22/2013 | EP2593438A1 Molecules having combinable groups |
| 05/22/2013 | CN103119045A Pyrrolopyrimidine compounds and uses thereof |
| 05/22/2013 | CN103119037A Phenylquinazoline derivatives |
| 05/22/2013 | CN103119028A 1,2,4-Triazolone Derivative |
| 05/22/2013 | CN103119025A Pyrimidine compounds as inhibitors of protein kinases ikk epsilon and/or tbk-1, processes for their preparation, and pharmaceutical compositions containing them |
| 05/22/2013 | CN103113355A Bcr/Abl tyrosine kinase inhibitor as well as preparation method and application thereof in treating chronic granulocytic leukemia |
| 05/22/2013 | CN103113354A PEGylated benzyltriazolyl pyridazinone compounds, and preparation method and application thereof |